早期磁共振成像对重型颅脑损伤危重患儿结局预测的价值
该研究基于单中心创伤登记数据,纳入2010—2021年收治的3—17岁重型颅脑损伤患儿(GCS<9)。260例中136例(52%)在伤后7天内完成MRI,中位时间3天。多变量模型控制年龄、入院前心肺复苏、瞳孔反应性、运动GCS评分及入院12小时内发热后显示,受限扩散区域数量(而非出血性弥漫性轴索损伤分级)与恢复执行指令时间延长(HR 0.68,95%CI 0.53—0.89)及WeeFIM评分更差(β -4.67,95%CI -8.33至-1.01)独立相关。作者认为早期MRI区域受限扩散与短期结局独立相关,需多中心队列研究验证。
要点
- 伤后7天内MRI受限扩散区域数量每增加一个,恢复执行指令时间延长(HR 0.68,95%CI 0.53—0.89),出院WeeFIM评分更差(β -4.67,95%CI -8.33至-1.01)。
- 出血性弥漫性轴索损伤分级与恢复执行指令时间及WeeFIM评分无独立关联。
- 136例早期MRI患儿中,胼胝体受限扩散75例(55%)、深部灰质29例(21%)、皮质下白质23例(17%)、脑干20例(15%)。
- 多变量模型控制的临床变量包括年龄、入院前心肺复苏、瞳孔反应性、运动GCS评分及入院12小时内发热(>38°C)。
- 作者结论认为早期MRI区域受限扩散与重型颅脑损伤患儿短期结局独立相关,但需多中心队列研究验证。
适用人群与场景
- 3—17岁、因重型颅脑损伤(GCS评分<9)于2010—2021年入住本中心的患儿,数据来自本中心创伤登记库。
- 260例患儿中136例(52%)在伤后7天内完成MRI,中位时间3天(IQR 2—4);该亚组中位年龄11岁(IQR 7—14),8例(6%)接受过心肺复苏,19例(14%)双侧瞳孔无反应,中位运动GCS评分1分(IQR 1—4),82例(60%)有发热。
诊断标准与关键阈值
- 重型颅脑损伤定义为GCS评分<9。
- 早期MRI定义为伤后7天内完成。
- 受限扩散区域计数包括皮质下白质、胼胝体、深部灰质和脑干四个区域。
- 出血性弥漫性轴索损伤分级按原文分级,Grade 3 DAI见于46例(34%)。
研究设计与关键结果
- 研究类型为基于单中心创伤登记库的队列研究,纳入260例3—17岁重型颅脑损伤(GCS<9)患儿,其中136例(52%)在伤后7天内完成MRI(中位3天,IQR 2—4)。
- 早期MRI亚组中,Grade 3 DAI 46例(34%),胼胝体受限扩散75例(55%)、深部灰质29例(21%)、皮质下白质23例(17%)、脑干20例(15%)。
- 控制年龄、入院前心肺复苏、瞳孔反应性、运动GCS评分及入院12小时内发热(>38°C)后,受限扩散区域数量增加与恢复执行指令时间延长独立相关(HR 0.68,95%CI 0.53—0.89),与出院WeeFIM评分更差独立相关(β -4.67,95%CI -8.33至-1.01)。
- 出血性DAI分级与恢复执行指令时间及WeeFIM评分无独立关联。
证据类型、等级与局限
- 证据类型:基于单中心创伤登记库的队列研究。
- 局限:作者指出需多中心队列研究验证这些发现,并阐明早期MRI特征与重型颅脑损伤患儿长期结局的关联。
对床旁实践的改变
- 作者认为,早期MRI上的区域受限扩散与重型颅脑损伤患儿的短期结局独立相关,可辅助结局预测。
- 作者指出,需多中心队列研究验证这些发现并阐明早期MRI特征与长期结局的关联。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Many children with severe traumatic brain injury (TBI) receive magnetic resonance imaging (MRI) during hospitalization. There are insufficient data on how different patterns of injury on early MRI inform outcomes.
METHODS: Children (3-17 years) admitted in 2010-2021 for severe TBI (Glasgow Coma Scale [GCS] score < 9) were identified using our site's trauma registry. We used multivariable modeling to determine whether the hemorrhagic diffuse axonal injury (DAI) grade and the number of regions with restricted diffusion (subcortical white matter, corpus callosum, deep gray matter, and brainstem) on MRI obtained within 7 days of injury were independently associated with time to follow commands and with Functional Independence Measure for Children (WeeFIM) scores at the time of discharge from inpatient rehabilitation. We controlled for the clinical variables age, preadmission cardiopulmonary resuscitation, pupil reactivity, motor GCS score, and fever (> 38 °C) in the first 12 h.
RESULTS: Of 260 patients, 136 (52%) underwent MRI within 7 days of injury at a median of 3 days (interquartile range [IQR] 2-4). Patients with early MRI were a median age of 11 years (IQR 7-14), 8 (6%) patients received cardiopulmonary resuscitation, 19 (14%) patients had bilateral unreactive pupils, the median motor GCS score was 1 (IQR 1-4), and 82 (60%) patients had fever. Grade 3 DAI was present in 46 (34%) patients, and restricted diffusion was noted in the corpus callosum in 75 (55%) patients, deep gray matter in 29 (21%) patients, subcortical white matter in 23 (17%) patients, and the brainstem in 20 (15%) patients. After controlling for clinical variables, an increased number of regions with restricted diffusion, but not hemorrhagic DAI grade, was independently associated with longer time to follow commands (hazard ratio 0.68, 95% confidence interval 0.53-0.89) and worse WeeFIM scores (estimate β - 4.67, 95% confidence interval - 8.33 to - 1.01).
CONCLUSIONS: Regional restricted diffusion on early MRI is independently associated with short-term outcomes in children with severe TBI. Multicenter cohort studies are needed to validate these findings and elucidate the association of early MRI features with long-term outcomes in children with severe TBI.
参考来源
- Janas AM, Miller KR, Stence NV, et al. Utility of Early Magnetic Resonance Imaging to Enhance Outcome Prediction in Critically Ill Children with Severe Traumatic Brain Injury. Neurocrit Care. 2023. PMID: 38148435. doi:10.1007/s12028-023-01898-9
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。